Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "AREA[SponsorSearch](Janssen Pharmaceuticals)"
Count: 2405
Selected: 0
NCT IDTitle
NCT03915886A Study of JNJ-64530440 in Healthy Japanese Male Participants
NCT02342249Study of Acute Uncomplicated Seasonal Influenza A in Adult Subjects
NCT00207688A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
NCT01026376An Expanded Access Program for Decitabine in Patients With Myelodysplastic Syndrome (MDS)
NCT06295692A Study of JNJ-77242113 for the Treatment of Participants With Generalized Pustular Psoriasis or Erythrodermic Psoriasis
NCT05926583A Study of AAV5-hRKp.RPGR for the Treatment of Japanese Participants With X-linked Retinitis Pigmentosa
NCT05567185A Study of Erdafitinib Intravesical Delivery System in Japanese Participants With Bladder Cancer
NCT05242432A Study of Adenovirus Serotype 26.Respiratory Syncytial Virus.Pre-Fusion F (Ad26.RSV.preF)-Based Vaccine for Prevention of Respiratory Syncytial Virus (RSV) Mediated- Lower Respiratory Tract Disease (LRTD) in Japanese Participants
NCT05167825A Study of Macitentan in Japanese Pediatric Participants With Pulmonary Arterial Hypertension
NCT05159128A Study of JNJ-75105186 in Healthy Japanese and Chinese Participants
NCT05062200A Study of JNJ-77242113 in Healthy Japanese and Chinese Participants
NCT05039710A Study of JNJ-75220795 in Japanese Participants
NCT04963725A Study of Symptom Improvement of Ulcerative Colitis After an Induction Dose of Ustekinumab in Japanese Clinical Practice
NCT04945733A Study of Amivantamab in Participants With Previously Treated Advanced or Metastatic Gastric or Esophageal Cancer
NCT04882072A Study of Ustekinumab in Participants With Takayasu Arteritis (TAK)
NCT04868916An Observational Study of Japanese Participants With X-linked Retinitis Pigmentosa
NCT04791332A Study of JNJ-67953964 in Healthy Japanese Adult Male Participants
NCT04773522A Study of JNJ-64407564 in Japanese Participants With Relapsed or Refractory Multiple Myeloma
NCT04713930A Study of JNJ-61393215 in Healthy Japanese Male Participants
NCT04696809A Study of Teclistamab in Japanese Participants With Relapsed or Refractory Multiple Myeloma
NCT04683029A Study of Guselkumab in Participants With Systemic Sclerosis
NCT04677530A Study of JNJ-40411813 in Healthy Japanese Male Participants
NCT04630145A Study of Bedaquiline Administered as Part of a Treatment Regimen With Clarithromycin and Ethambutol in Adult Patients With Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD)
NCT04509947A Study of Ad26.COV2.S in Adults (COVID-19)
NCT04500808A Study of Macitentan, in Healthy Japanese Male Participants
NCT04459507A Registry Study of Palmoplantar Pustulosis (PPP) Treatment Patterns, Disease Burden and Treatment Outcomes in Japan
NCT04397263A Study of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
NCT04354480A Study to Evaluate the Single Vaccination of an Adenovirus Serotype 26 Pre-Fusion F (Ad26.preF) Based Respiratory Syncytial Virus (RSV) Vaccine in Japanese Adults Aged 60 Years and Older
NCT04325828A Study of Apalutamide Combined With GnRH Agonist in Participants With Androgen Receptor Positive Salivary Gland Carcinoma
NCT04306302A Study to Evaluate the Different Doses of VAC52416 (ExPEC10V) in Japanese Adults
NCT04062448A Study of Ibrutinib in Combination With Rituximab, in Japanese Participants With Waldenstrom's Macroglobulinemia (WM)
NCT04034095A Registry Study to Observe Clinical Outcomes of Participants With High-risk Metastatic Hormone-naïve Prostate Cancer in Japan
NCT03981744A Study of Ustekinumab in Participants With Active Polymyositis and Dermatomyositis Who Have Not Adequately Responded to One or More Standard-of-care Treatments
NCT03689153A Study of JNJ-63733657 in Healthy Japanese Participants
NCT03618160A Study to Assess the Safety, Tolerability and Pharmacokinetics of Subcutaneous (SC) Injections of JNJ-64565111 in Healthy Male Japanese Participants and to Assess Pharmacokinetics Following Subcutaneous Injections of JNJ-64565111 in Healthy Male Caucasian Participants
NCT03547037A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of JNJ-63723283, an Anti-Programmed Cell Death (PD)-1 Monoclonal Antibody, as Monotherapy or in Combination With Erdafitinib in Japanese Participants With Advanced Solid Cancers
NCT03536325A Study to Assess the Safety, Tolerability and Pharmacokinetics of Guselkumab Following a Single Intravenous Administration in Healthy Japanese Participants
NCT03474679A Study of the Bruton's Tyrosine Kinase (BTK) Inhibitor Ibrutinib in Participants With Steroid Dependent/Refractory Chronic Graft Versus Host Disease (cGVHD)
NCT03398876A Study to Assess the Nicotine Pharmacokinetics, Tolerability and Safety With a New Oral Nicotine Replacement Product in Healthy Japanese Smokers
NCT03242889A Study of Subcutaneous Delivery of JNJ-54767414 (Daratumumab) in Japanese Participants With Relapsed or Refractory Multiple Myeloma
NCT03123848A Study to Evaluate the Pharmacokinetics (PK) of Darunavir (DRV) and Cobicistat (COBI) After a Single Oral Administration of Darunavir/Cobicistat Fixed-Dose Combination in Healthy Japanese Adult Participants
NCT03002025A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Following Subcutaneous Injection of JNJ-64304500 in Healthy Japanese and Caucasian Male Participants
NCT02993250A Study to Investigate the Safety, Pharmacokinetics, and Efficacy of Combination Treatment of AL-335, Odalasvir, and Simeprevir in Japanese Participants With Chronic Hepatitis C Genotype 1 or 2 Virus Infection, With or Without Compensated Cirrhosis Who Are Direct Acting Antiviral Treatment-naive
NCT02918331A Study of JNJ-54767414 (Daratumumab) in Combination With Lenalidomide and Dexamethasone in Japanese Participants With Previously Untreated Multiple Myeloma Who Are Ineligible for High-dose Therapy and Autologous Stem Cell Transplantation
NCT02918318A Study to Evaluate the Efficacy, Safety and Tolerability of Fixed Doses of Intranasal Esketamine in Japanese Participants With Treatment Resistant Depression
NCT02895815Efficacy and Safety Study of CNTO 2476 in Participants With Visual Acuity Impairment Associated With Geographic Atrophy (GA) Secondary to Age Related Macular Degeneration (AMD)
NCT02835508Pharmacokinetic Study of JNJ-56021927 When Taken Orally as Tablet Formulation in Healthy Male Japanese Participants
NCT02748967A Study to Evaluate the Safety and Immunogenicity of Different Doses of ExPEC4V (JNJ-63871860) in Healthy Japanese Adult Participants
NCT02641730An Efficacy and Safety of Guselkumab in Participants With Palmoplantar Pustulosis
NCT02556892A Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Ibrutinib in Participants With Treatment-naive Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma